Caredx

This study follows 1,500 liver transplant patients over time to see if a new set of blood tests (called LiverCare) can catch problems like rejection, infection, or bile duct blockages earlier than the usual methods. Participants will have extra blood draws alongside their standar…

This study is testing a new blood test called AlloHeme that looks at DNA to see if a patient's own cells are coming back after a bone marrow transplant. The goal is to find out if this test can predict a relapse of leukemia or myelodysplastic syndrome earlier than current methods…

This study follows over 2,700 heart transplant recipients to see if routine HeartCare blood tests can help doctors detect early signs of organ rejection. Participants are monitored for up to 5 years after their transplant. The goal is to understand how well these tests work in ev…

This study is testing a new blood test called AlloSure Lung to see if it can detect early signs of lung transplant rejection or infection. Researchers are following 550 lung transplant patients to measure how accurate the test is. The goal is to find problems sooner, so doctors c…